Xbox Kinect Training in Men With Prostate Cancer

February 27, 2019 updated by: Brigitta R. Villumsen, Hospitalsenheden Vest

Xbox Kinect Training in Men With Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy

The purpose of this study is to investigate the effect of 12 weeks systematically training using the Xbox Kinect system.

Outcome measures are made on physical function, quality of life, fatigue and metabolic parameters.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients will be recruited from the outpatient clinic at the urological department, Regionshospitalet Holstebro.

Patients who have been discharged from the outpatient clinic due to biochemical stabile cancer prostate disease will receive a letter with information about the study.

A research assistant will be responsible for randomization and test procedures. A physiotherapist will be responsible for instruction of the participants to the training and the Xbox system.

A student will be responsible for installation and collection of the Xbox system in the participants home.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark, 8000
        • Urinvejskirurgisk afdeling, Aarhus Universitetshospital, Skejby
      • Holstebro, Denmark, 7500
        • Regionshospitalet Holstebro, Urinvejskirurgisk afdeling
      • Viborg, Denmark, 8800
        • Urologisk afdeling, Regionshospitalet Viborg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Prostate cancer requiring androgen deprivation therapy
  • Androgen deprivation therapy for at least 3 month prior to inclusion
  • Cognitive well-functioning in order to be able to answer questionnaires and train according to instructions
  • Signed informed consent

Exclusion Criteria:

  • Prostate cancer with metastasis to other regions than bones
  • Strength- or cardiovascular training 2 times or more per week prior to inclusion
  • Haemoglobin percentage less than 6,1 mmol/l
  • Any mental or physical condition that makes the patient unfit for participation
  • Men in risk of getting an osteoporotic fracture due to long-term treatment with steroids or earlier fractures due to minimal trauma
  • Participation in other studies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
12 weeks systematically home based training 3 times per week one hour at the time using the Xbox Kinect system.
Home based training 3 times a week for 12 weeks using the Xbox Kinect system
No Intervention: Control group
No systematically training/standard of care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of 12 weeks systematically training with the Xbox Kinect system on physical function
Time Frame: Change from baseline to week 12
6 min walk test
Change from baseline to week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effect of 12 weeks systematically training with the Xbox Kinect on body composition
Time Frame: Change from baseline to week 12
Method: BIoelectrical impedance analysis Bioelectrical impedance
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on physical function
Time Frame: Change from baseline to week 12
Leg extensor power
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on fatigue
Time Frame: Change from baseline to week 12
Fatigue measured using the Functional Assessment of Canter Therapy-Fatigue questionnaire
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on quality of life
Time Frame: Change from baseline to week 12
Quality of life measured using the Functional Assessment of Canter Therapy-Prostate questionnaire
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12
Waist circumference (cm)
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12
Blood pressure (mmHg)
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12
Body weight (kg)
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Blood glucose (mmol/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Plasma triglyceride (mmol/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Plasma cholesterol (mmol/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Plasma High-density lipoprotein (HDL-cholesterol) (mmol/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Plasma Low-density lipoprotein (LDL-cholesterol) (mmol/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Leptin (µg/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Adiponectin (mg/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on metabolic parameters
Time Frame: Change from baseline to week 12 and week 24
Leptin:Adiponectin ratio
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on the prevalence of the metabolic syndrome
Time Frame: Change from baseline to week 12
The five components of the metabolic syndrome: blood glucose, triglyceride, HDL-cholesterol, waist circumference, blood pressure
Change from baseline to week 12
The effect of 12 weeks systematically training with the Xbox Kinect system on insulin
Time Frame: Change from baseline to week 12 and week 24
Insulin (pmol/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on insulin resistance
Time Frame: Change from baseline to week 12 and week 24
Homeostasis model assessment for insulin resistance (HOMA-IR)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor-I (IGF-I), bioactive IGF, and IGF-II
Time Frame: Change from baseline to week 12 and week 24
IGF-I, bioactive IGF and IGF-II (µg/L)
Change from baseline to week 12 and week 24
The effect of 12 weeks systematically training with the Xbox Kinect system on Insulin Growth Factor Binding Protein 1-3 (IGFBP 1-3)
Time Frame: Change from baseline to week 12 and week 24
IGFBP 1-3 (µg/L)
Change from baseline to week 12 and week 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brigitta R Villumsen, M.S.N., Hospitalsenheden Vest

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2015

Primary Completion (Actual)

June 1, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

December 20, 2012

First Submitted That Met QC Criteria

January 4, 2013

First Posted (Estimate)

January 7, 2013

Study Record Updates

Last Update Posted (Actual)

March 1, 2019

Last Update Submitted That Met QC Criteria

February 27, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • Wii-1-10-72-593-12
  • 1-10-72-593-12 (Other Identifier: Hospitalsenheden Vest)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prostate Cancer

Clinical Trials on Home based training using the Xbox Kinect system

3
Subscribe